Acquisition highlights of MedGenome and a snapshot of its key metrics.

Founded in 2013, MedGenome is a genomics and diagnostics company. The health tech company offers advanced genetic testing across oncology, cardiology, and reproductive health. The soonicorn began with clinical genomics services and gradually expanded into full-spectrum sequencing and precision diagnostics. In 2024, MedGenome acquired stakes in GenX Diagnostics and Prognosis Labs to strengthen its presence in East India and broaden its testing capabilities. With a revenue of Rs 299.27 Cr in FY24, MedGenome competes with companies including Strand Life Sciences and MapMyGenome.

Mahesh Pratapneni

Sam Santhosh

Founded in 2013, MedGenome has raised 233.00 Mn+ in funding from a total number of 14 investors.

MedGenome – Total Funding, Funding Over Time, Funding By Rounds and More.

Funding highlights of MedGenome and a snapshot of its key metrics.

Peak XV Partners

Sofina

LeapFrog Investments

Novo Holdings

International Finance Corporation

Zodius Capital

HDFC Mutual Fund

HDFC ERGO General Insurance Company Limited

HDFC Standard Life Insurance

Papillon Capital

Vidinovo

Emerge Life Sciences

Sequoia Capital

Investment highlights of MedGenome and a snapshot of its key metrics.

Medgenome - A Health Tech Funded Company Based Out Of Bengaluru

MedGenome

A snapshot of highlights, scale, and metrics

A Health Tech Funded Company Based Out Of Bengaluru

MedGenome - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More